ZY News

Recent IPOs saw their valuations collapse in 2022, but as public investors sit on the sidelines, buyout firms and corporations are hunting for bargains amid the IPO wreckage. For companies that have gone public via IPO or SPAC merger since 2015, more than 40 have received, agreed to, or completed buyout offers since the start of 2022. Healthcare companies ...read more

Sock maker Bombas is the latest company preparing to ride the ESG investing wave, with the certified B Corp reportedly considering an IPO as soon as this year. It would join Greek yogurt brand Chobani (CHO) in the IPO pipeline, which filed last November as a public benefit corporation (PBC) to raise an estimated $1.5 billion. To date,...read more

12 IPOs raised $3.7 billion this past week, led by software maker UiPath (PATH), which raised more than $1 billion in its public debut. The pipeline remained active, with 11 IPOs and one direct listing submitting initial filings. SPAC activity continued to decline, with no pricings for the first week ever in 2021 and just four new filings. The largest deal...read more

Zymergen, which is developing biomanufacturing technologies for materials and chemicals, raised $500 million by offering 16.1 million shares at $31, the high end of the range of $28 to $31. The company offered 2.5 million more shares than anticipated. At pricing, Zymergen commands a fully diluted market value of $3.2 billion.  Zymergen designs, develops, and commercializes...read more